Analysis of the liver soluble proteome from bull terriers affected with inherited lethal acrodermatitis.
Lethal acrodermatitis (LAD) is a genetic disease affecting bull terrier dogs. The phenotype is similar to that for acrodermatitis enteropathica in humans, but is currently without treatment. The purpose of the research presented here is to determine the biochemical defects associated with LAD using proteomic methodologies. Two affected (male and female) and one unaffected (male) bull terrier pups were euthanized at 14 weeks of age, their livers dissected and prepared for two-dimensional gel electrophoresis (2DE) and densitometry. Approximately 200 protein spots were observed. The density of the spots within each gel was normalized to the total spot volume of the gel; only those soluble liver protein spots that were consistently different in both of the livers of the affected pups compared to the unaffected pup were excised manually and submitted for MALDI mass spectrometry. Thirteen proteins were identified as differentially expressed in the affected, compared to the unaffected, pups. The proteins were involved in numerous cellular physiological functions, including chaperones, calcium binding, and energy metabolism, as well as being associated with the inflammatory response. Of note were haptoglobin, glutamine synthetase, prohibitin and keratin 10 which exhibited at least a fourfold level of differential expression. These data represent the first proteomic analysis of this mutation. The differentially expressed proteins that were identified may be key in understanding the etiology of LAD, and may lead to diagnostic tools for its identification within the bull terrier population.
Grider
Arthur
A
University of Georgia, Department of Foods and Nutrition, 171 Dawson Hall, Athens, GA 30606, USA. agrider@fcs.uga.edu
Mouat
Michael F
MF
Mauldin
Elizabeth A
EA
Casal
Margret L
ML
D000169:Acrodermatitis / Q000235:genetics / Q000378:metabolism / Q000662:veterinary*; D000818:Animals; D004283:Dog Diseases / Q000235:genetics / Q000378:metabolism*; D004285:Dogs; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D008099:Liver / Q000378:metabolism*; D008110:Liver Extracts; D008297:Male; D010449:Peptide Mapping; D020543:Proteome / Q000378:metabolism*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D015996:Survival Rate
D008110:Liver Extracts; D020543:Proteome
J Appl Physiol (1985). 2004 Aug;97(2):605-11
15075301
Nat Genet. 2002 Jul;31(3):239-40
12068297
Lancet. 1974 Aug 17;2(7877):399-400
4136854
J Pediatr. 1978 Jul;93(1):71-3
650348
Growth. 1978 Mar;42(1):1-6
669395
Physiol Rev. 1985 Apr;65(2):238-309
3885271
J Am Vet Med Assoc. 1986 Apr 15;188(8):833-9
3710872
J Am Coll Nutr. 1988 Jun;7(3):249-50
3392358
Vet Immunol Immunopathol. 1989 Jul;21(3-4):239-48
2800326
Biol Trace Elem Res. 2003 Jan;91(1):77-87
12713031
Arch Toxicol. 2003 Jul;77(7):392-402
12669191
Biochem J. 2004 Mar 15;378(Pt 3):929-37
14678012
Am J Dis Child. 1991 Feb;145(2):211-2
1994690
Arch Oral Biol. 1991;36(10):759-63
1720954
Am J Clin Nutr. 1996 May;63(5):797S-811S
8615367
J Vet Diagn Invest. 1996 Apr;8(2):219-27
8744744
Am J Vet Res. 1997 Aug;58(8):808-10
9256960
J Biol Chem. 2005 May 6;280(18):17626-33
15760893
Free Radic Biol Med. 2005 Sep 1;39(5):631-40
16085181
Proteomics. 2006 Mar;6(5):1460-70
16429458
Free Radic Biol Med. 2006 Apr 15;40(8):1430-42
16631533
Proteomics. 2006 Jun;6(11):3381-8
16637013
J Cell Mol Med. 2006 Apr-Jun;10(2):353-63
16796804
Med Mycol. 2006 Aug;44(5):399-404
16882606
Genomics. 2006 Oct;88(4):521-6
16714095
Mol Immunol. 2007 Mar;44(8):1897-902
17070910
FASEB J. 2007 Jan;21(1):197-206
17135366
Dtsch Tierarztl Wochenschr. 2007 Jan;114(1):25-9
17252933
Cell Death Differ. 2000 Feb;7(2):137-44
10713728
J Biol Chem. 2000 May 5;275(18):13213-8
10788425
J Biol Chem. 2000 May 12;275(19):14139-46
10799490
J Small Anim Pract. 2000 Nov;41(11):501-7
11105789
Vet Dermatol. 2001 Apr;12(2):101-9
11360336
Cell Mol Life Sci. 2004 Sep;61(18):2405-17
15378209